Miles White, who reshaped Abbott Laboratories over the past decade through big deals, is positioned for another game-changer. Pharmaceutical companies are expected to go on buying sprees this year for potential blockbuster drugs at bargain prices.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Abbott Laboratories News | Chicago Business News, Analysis & Articles | Abbott dealmaker set to strike
Please enter your email address and password. Not a member? Join now
